Aspen Aerogels, Inc. $ASPN Shares Sold by Dimensional Fund Advisors LP

Key Points

• Dimensional Fund Advisors cut its Aspen Aerogels stake by 37.3% in the first quarter, selling 747,483 shares and retaining 1.26 million shares valued at about $4.3 million. Institutional investors and hedge funds collectively own 97.64% of ASPN.
• Analyst sentiment is mixed: four analysts rate the stock Buy, one Hold and two Sell, resulting in a consensus Hold rating and an average price target of $5.94.
• Aspen Aerogels reported quarterly revenue of $49.85 million, above the $42.42 million estimate, while its adjusted loss of $0.22 per share narrowly beat expectations. Shares opened at $6.09, and the company provided third-quarter guidance of a $0.11–$0.07 loss per share.

Dimensional Fund Advisors LP lessened its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 37.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,256,480 shares of the construction company's stock after selling 747,483 shares during the quarter. Dimensional Fund Advisors LP owned 1.52% of Aspen Aerogels worth $4,296,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ASPN. Drive Wealth Management LLC acquired a new stake in shares of Aspen Aerogels during the fourth quarter worth about $30,000. Caitong International Asset Management Co. Ltd purchased a new stake in Aspen Aerogels in the fourth quarter valued at approximately $30,000. Clarus Group Inc. acquired a new position in Aspen Aerogels in the 1st quarter worth approximately $36,000. WINTON GROUP Ltd acquired a new position in Aspen Aerogels in the 4th quarter worth approximately $40,000. Finally, StoneX Group Inc. purchased a new position in Aspen Aerogels during the 4th quarter worth approximately $41,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ASPN has been the subject of several recent research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Barclays boosted their price objective on Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a research report on Tuesday. B. Riley Financial reiterated a "buy" rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Roth Capital reissued a "buy" rating and issued a $7.75 price target on shares of Aspen Aerogels in a research note on Friday, August 7th. Finally, Wall Street Zen raised shares of Aspen Aerogels from a "sell" rating to a "hold" rating in a report on Saturday, May 16th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $5.94.

Aspen Aerogels Stock Down 0.8%

Shares of ASPN opened at $6.09 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.54 and a current ratio of 2.89. Aspen Aerogels, Inc. has a one year low of $2.30 and a one year high of $9.35. The stock has a market capitalization of $505.41 million, a price-to-earnings ratio of -3.98 and a beta of 2.99. The stock has a 50 day moving average price of $5.51 and a 200 day moving average price of $4.48.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative return on equity of 29.30% and a negative net margin of 62.45%.The company had revenue of $49.85 million for the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. Equities research analysts forecast that Aspen Aerogels, Inc. will post -0.69 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source